Regorafenib use as a possible cause of intestinal perforation

Acta Oncol. 2013 Nov;52(8):1789-90. doi: 10.3109/0284186X.2013.835070. Epub 2013 Sep 12.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / pathology
  • Disease Progression
  • Fatal Outcome
  • Female
  • Gastrointestinal Stromal Tumors / drug therapy*
  • Gastrointestinal Stromal Tumors / pathology
  • Humans
  • Intestinal Perforation / chemically induced*
  • Male
  • Peritoneal Neoplasms / drug therapy*
  • Peritoneal Neoplasms / secondary
  • Phenylurea Compounds / adverse effects*
  • Pyridines / adverse effects*

Substances

  • Phenylurea Compounds
  • Pyridines
  • regorafenib